Nasal spray flu vaccine study for adults 18 to 59
Part of Ear, nose & throat, Infections clinical trials.
This study tests if a new nasal spray flu vaccine is safe and effective for preventing flu in healthy adults aged 18 to 59. If you've had the flu recently or have certain health conditions, this trial may not be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 59 years old
- You are generally healthy
- You have not had the flu in the past 6 months
- You have not had a flu vaccine in the past 6 months
- You are not pregnant, breastfeeding, or planning pregnancy in the next 6 months (if female)
- You do not have a history of severe allergies or immune system problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how healthy adults respond to the nasal flu vaccine. You may be able to help researchers learn more about how the body reacts to this vaccine.
This trial tests a flu vaccine (split virus type) for adults aged 60+ to see how well it works and how safe it is. It might help protect older adults from the flu.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This study measures how your child's body builds immunity after receiving a nasal spray flu vaccine. Researchers will collect samples to understand how the vaccine triggers the immune system to protect against influenza.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
Hear when a new Prevention of Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.